The comparability of patient characteristics between two study groups was achieved by the three-step matching on (1) the index date, (2) prior exposure to GLAs in the year before the index date, and (3) patient demographic and clinical characteristics (e.g., diabetes severity, comorbidities, co-medications for cardiovascular diseases [CVDs]) using the propensity score matching approach [6]
The key takeaway is that you, the researcher, are in control of the final concentration
While this can occur with UTIs, it can also indicate other conditions that need evaluation
With the rise of GIP/GLP-1 agonists such as tirzepatide (Mounjaro, Zepbound) and GLP-1 agonists like semaglutide (Ozempic, Wegovy) for type 2 diabetes and obesity, many women wonder if they need to change their birth control method
There are currently three barriers to more interaction between providers of sleep medicine services and specialists in endocrinology, diabetes, metabolism or weight loss clinics, Dr
On the flip side, the drugs can cause gastrointestinal problems including diarrhea, constipation, nausea and vomiting